qtr-three adjusted earnings per share $num-one.
qtr-three revenue $num-one million versus refinitiv ibes estimate of $1.04 billion.
sees fy year-six adjusted earnings per share $num-three to $4.00 excluding items.
compname announces agreement to acquire z-medica for $num-one million in cashback and up to an additional $num-$two million in share repurchases.
compname announces expanded indication for ez-io for up to num-one hours of use in both adults and pediatric patients, num-two years and older.
qtr-three adjusted earnings per share $num-one excluding items.
qtr-four revenue fell num-two percent to $num-one million.
qtr-three adjusted earnings per share $num-one excluding items.
qtr-three revenue $num-one million versus refinitiv ibes estimate of $1.04 billion.
qtr-three adjusted earnings per share $num-two.
compname reports qtr-four constant currency revenue growth of num-one%.
qtr-four adjusted gross profit $num-one million versus $num - two million.
qtr-three revenue rose num-two percent to $num-one million.
sees qtr-three underlying decline of about num-one% due to covid.
compname reports qtr-three year-six results and announces $num-one million cash dividend.
qtr-three revenue $num-one million versus refinitiv ibes estimate of $1.87 billion.
